Epilepsy

The premature death rate for epilepsy patients is approximately three times higher than the general population, so the need for testing new treatments is high. That is where we come in.

Julius Clinical is devoted to providing the high-quality trial design, setup, and execution our Sponsors need in epilepsy trials. We leverage scientific networks and neurologists with access to large patient groups to deliver the best possible epilepsy clinical trial experience.

Our scientific leader for epilepsy

Julius Clinical works closely with world-class scientific experts across our therapeutic focus areas to provide industry- leading epilepsy CRO services. Our scientific leader in epilepsy trials is Prof. dr. Eugen Trinka, chair of the department of neurology at Paracelsus Medical University Salzburg and president-elect of the Austrian Society of Neurology.

Brain Clinical is Julius Clinical’s proprietary network for CNS clinical trials. This network includes highly experienced and devoted researchers who specialize in streamlined and rigorously executed clinical trials for Alzheimer’s disease treatments.


Julius Clinical partners with the European Collaboration for Epilepsy Trials (ECET), a consortium of expert investigators who collaborate within the framework of the Epilepsy Alliance Europe. This partnership allows us to provide Sponsors with access to specialised epilepsy centres with investigators who are experienced in designing and conducting clinical epilepsy studies.

Read more

We have the experience and capability to conduct trials that require advanced tools for the measurement of brain functioning, including MRI/fMRI, PET, and EEG. Our academic partners at UMC Utrecht’s epilepsy centre have published extensively in this area, and ECET brings world-class expertise on epilepsy trial design and execution. 

We currently have one Phase II epilepsy trial ongoing (180 patients) and a Phase III trial that will begin soon.


Our expert epilepsy team

Julius Clinical brings tremendous scientific and operational expertise to the table in epilepsy clinical trials. Our internal expert team and relentless devotion to scientific standards are your advantage in the innovative design and efficient execution of rigorous epilepsy studies.

Maria papakrasa
Lieza exalto

Related webinars

The Alzheimer’s disease drug development landscape

Hosted by: Julius Clinical. Speakers: Pieter van Bokhoven | CSO| IAO Amsterdam Neuroscience AUMC Jort Vijverberg | Neurologist | Amsterdam Neuroscience AUMC Topics that are discussed during this webinar: All major trends in Alzh...

Speakers: Dr. Jort Vijverberg

Epilepsy scientific insights

Explore our Epilepsy trial capabilities, case studies, and other resources.

Download

"*" indicates required fields

*

Request for proposal

"*" indicates required fields

*
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn